Sign in

Pat Sharp

@patsharp.bsky.social
590 followers 1.3K following 176 posts

Drug developer | Co-founder of Gate Bio | Fmr Big Pharma | Inventing small molecule medicines | Artist | Polymath

PostsRepliesMedia
Pat Sharp @patsharp.bsky.social · 05/04/2026
Peptides are the poor person’s pharmaceuticals. GLP-1 agonists didn’t show that peptides are the future. They proved the GLP-1 biology was an amazing opportunity and worth re-engineering into a small molecules.
010
Pat Sharp @patsharp.bsky.social · 01/04/2026
Fascinating story that ends in a cancer drug. podcasts.apple.com/au/podcast/a...
podcasts.apple.com
Episode #2: Geron
Podcast Episode · Approved · 13 March · 2h 22m
010
Pat Sharp @patsharp.bsky.social · 24/02/2026
A completey novel series of protease inhibitors from my time at Merck pubs.acs.org/doi/10.1021/...
pubs.acs.org
N-Alkyl and N-Aryl Aminopyrazole Spirocarbamates: A Two-Pronged Lead Optimization Strategy to Identify Orally Bioavailable Plasma Kallikrein Inhibitors
Plasma kallikrein (pKal) is a trypsin-like serine protease involved in the kallikrein-kinin, renin-angiotensin, and complement pathways, making it an attractive target for diseases, such as hereditary angioedema, diabetic mellitus complications, and cerebrovascular disorders. As part of an internal program to develop orally bioavailable small-molecule pKal inhibitors, we report lead optimization efforts within the spirocarbamate scaffold, highlighting a structure-based drug design strategy to engineer hydrogen bond interactions with N-benzyl aminopyrazoles. Additionally, mitigation of time-dependent inhibition (TDI) liability and optimization of the overall profile were achieved through a two-pronged strategy: (1) incorporating increased Fsp3 modifications via N-alkylation and (2) leveraging torsional strain in N-aryl analogs.
020
Pat Sharp @patsharp.bsky.social · 13/02/2026
hellyeah.xyz/p/gatebiosci...
hellyeah.xyz
Gate Bioscience: Slamming the door on disease
🇺🇸 Gate Bioscience: Revolutionary 'molecular gate' drugs that act like cellular bouncers, blocking disease-causing proteins and unlocking groundbreaking treatments for previously untreatable condition...
000
Pat Sharp @patsharp.bsky.social · 13/01/2026
Here’s where I think AI is going to rapidly impact in drug discovery. In this awesome paper from Roche they screen ~6% of a 2-million-compound library, and recover ~43% of all hits found in a full brute-force HTS, including essentially all the hit series. pubs.acs.org/doi/10.1021/...
pubs.acs.org
Machine Learning-Assisted Iterative Screening for Efficient Detection of Drug Discovery Starting Points
High-throughput screening (HTS) remains central to small molecule lead discovery, but increasing assay complexity challenges the screening of large compound libraries. While retrospective studies have...
100
Pat Sharp @patsharp.bsky.social · 30/12/2025
What a year for biotech
010
Pat Sharp @patsharp.bsky.social · 28/12/2025
Wegovy began as a diabetes drug and became a weight-loss breakthrough. JAK inhibitors were originally designed for cancer, now for hairloss. Cosmetic uses expand capital and demand and the science bleeds back into medicine. Net gain.
110
Pat Sharp @patsharp.bsky.social · 27/12/2025
Merry Christmas from Australia
010
Reposted by Pat Sharp
C&EN (Chemical & Engineering News) @cenmag.bsky.social · 23/12/2025
Researchers recently announced an advance in pharmacologists’ long-term goal to make a compound that could preserve the pain relief but ditch the undesirable side effects. cen.acs.org/biological-c... #chemsky 🧪
cen.acs.org
Opioid receptor agonists take advantage of new understanding of GPCR biology
Tool compounds separate pain relief from breathing suppression in mice
0116
Reposted by Pat Sharp
Carolyn Bertozzi @carolynbertozzi.bskyverified.social · 22/12/2025
Wow, exciting convergence of chem bio technologies in this paper! 🤯
1327
Pat Sharp @patsharp.bsky.social · 22/12/2025
The cryo-EM structure of a TnaC–ribosome complex shows how L-tryptophan stalls translation via a sequence-specific pocket in the exit tunnel (pubmed.ncbi.nlm.nih.gov/34403461)  This is in prokaryotes but I’d bet the mechanism exists in eukaryotes. #biotech #drugdiscovery #cryoEM #blueskybiotech
pubmed.ncbi.nlm.nih.gov
Structural basis of l-tryptophan-dependent inhibition of release factor 2 by the TnaC arrest peptide - PubMed
In Escherichia coli, elevated levels of free l-tryptophan (l-Trp) promote translational arrest of the TnaC peptide by inhibiting its termination. However, the mechanism by which translation-termination by the UGA-specific decoding release factor 2 (RF2) is inhibited at the UGA stop codon of stalled …
030
Pat Sharp @patsharp.bsky.social · 01/12/2025
OK this is now in the useable realm. Gemini beats chatGPT at schematic diagrams.
100
Pat Sharp @patsharp.bsky.social · 15/11/2025
Great news from Gate Bio! This Series B validates our differentiated approach: turning the cell’s single protein exit channel into a precision therapeutic target. www.gatebio.com/gate-bioscie...
gatebio.com
Gate Bioscience Announces $65 Million Oversubscribed Series B Financing to Advance Oral Molecular Gate Medicines into the Clinic
New funding brings total capital raised to $135 million. Molecular gates offer the convenience of a pill with potential for superior efficacy through a novel mechanism that eliminates disease-causing ...
100
Pat Sharp @patsharp.bsky.social · 11/10/2025
When are all the US scientists moving to Australia?
011
Pat Sharp @patsharp.bsky.social · 21/09/2025
That new name…Genetix…wow
010
Pat Sharp @patsharp.bsky.social · 14/09/2025
If someone argues that living “in nature” is inherently healthier, cats and dogs provide a counterexample: they clearly live longer, on average, when removed from “natural” conditions.
000
Pat Sharp @patsharp.bsky.social · 11/09/2025
020
Pat Sharp @patsharp.bsky.social · 12/08/2025
You’ve got to be kidding - I’m good thanks
020
Pat Sharp @patsharp.bsky.social · 25/07/2025
Let’s Go!!
110
Pat Sharp @patsharp.bsky.social · 09/07/2025
www.genengnews.com/topics/drug-... #chemsky #biotech
110
Pat Sharp @patsharp.bsky.social · 07/07/2025
Home
020
Pat Sharp @patsharp.bsky.social · 07/07/2025
Chat can use the RDkit #chemsky
120
Pat Sharp @patsharp.bsky.social · 19/06/2025
Everyone wants to meet on Zoom again, rather than in person. Has the promise of the return to office in-person productivity and relationship building failed to deliver?
010
Pat Sharp @patsharp.bsky.social · 31/05/2025
The origin from chirality - from amino acids to pasta 🍝
120
Pat Sharp @patsharp.bsky.social · 03/05/2025
www.chemistryworld.com/news/harvard... #chemsky
chemistryworld.com
Harvard’s former chemistry chair takes new position at Chinese university
Charles Lieber, the nanoscience pioneer convicted for not disclosing his ties to China, has just joined Tsinghua University
010
Pat Sharp @patsharp.bsky.social · 28/04/2025
The Shine Dome - home of the Australian Academy of Science - Canberra ACT. It’s my favourite building in Australia. I’d love to give a seminar here one day. #chemsky #australia #science #architecture
040
Pat Sharp @patsharp.bsky.social · 19/04/2025
Presenting on Molecular Gates at the RACI MCCB conference 2025. #chemsky #chembio #biotech #pharma
130
Pat Sharp @patsharp.bsky.social · 16/04/2025
Chat getting better at organic molecules. Asked for alprazolam. Got the chlorine atom. Almost got the benzodiazepine and almost got the triazole. How many months until it starts to nail it?
100
Pat Sharp @patsharp.bsky.social · 16/04/2025
I was thinking about how we draw organic molecules — those 2D skeletal structures we all know — and I stumbled into an old mathematical idea that made me stop in my tracks. Turns out, the number of continuous lines you need to draw any molecule can be predicted.
100
Pat Sharp @patsharp.bsky.social · 07/04/2025
50g ATP processed in a few SECONDS…gone…let that sink in. Muscles
110
Pat Sharp @patsharp.bsky.social · 04/04/2025
Glad I’m living back in Aus again amp.abc.net.au/article/1050...
amp.abc.net.au
020
Reposted by Pat Sharp
Scott Bagley @bagphos.bsky.social · 01/04/2025
One thing you can count on from me is to share great synthesis. While we may be competitors, I’ll highlight this review of #MerckChemistry innovations in #JOCasap from my respected industry colleague and friend @drlcsquare.bsky.social The work here is inspiring and drives us to our best #ChemSky
pubs.acs.org
From Cortisone to Enlicitide: A Journey of Synthetic Chemistry Innovations at Merck
Necessity is the mother of invention. Most synthetic chemistry innovations are driven by our desire to make molecules. In the first half of the 20th century, much of this work was inspired by natural ...
43710
Pat Sharp @patsharp.bsky.social · 15/03/2025
Any progress on new approaches to pain are welcomed. Here I like that chemical modification affecting the distribution is a key design principle. www.nature.com/articles/s41...
100
Pat Sharp @patsharp.bsky.social · 15/03/2025
Pretty impressive. Would be useful for organizing competitive patent data.
131
Reposted by Pat Sharp
Marcelo Bonini, Ph.D. @mbonini.bsky.social · 13/03/2025
The story of Taxol another NIH gift that saved millions of lives - In the 1960 the National Cancer Institute led a search for plant based medicines that could help fight cancer - that was when four botanists collecting samples from plants native to the US west coast came across Western Yew tree 🧵
1535595
Pat Sharp @patsharp.bsky.social · 14/03/2025
Don’t want to overhype this. But it’s certainly interesting. “Notably, we demonstrated the relevance of this FABP5-mTORC1 signaling pathway in vivo by feeding animals a diet enriched for safflower oil that promoted TNBC tumor growth.”
110
Pat Sharp @patsharp.bsky.social · 14/03/2025
Psychedelics might be a good starting point for this project.
010
Pat Sharp @patsharp.bsky.social · 12/03/2025
Looks like the residue in the bottom of the flask during my PhD
100
Pat Sharp @patsharp.bsky.social · 12/03/2025
More weight-loss peptides
100
Pat Sharp @patsharp.bsky.social · 11/03/2025
Not having to rely on E3s for degradation has some nice advantages. www.biorxiv.org/content/10.1...
biorxiv.org
A pharmacological modality to sequester homomeric proteins
Molecules that can perturb protein-protein interactions have an immense impact on chemical biology and therapeutics. However, such compounds typically rely on accessory proteins to function, such as E...
010
Pat Sharp @patsharp.bsky.social · 10/03/2025
Great idea!
110
Pat Sharp @patsharp.bsky.social · 10/03/2025
Ascorbic acid! It must be from alien blood!
000
Pat Sharp @patsharp.bsky.social · 10/03/2025
Generated by chatGPT and SankeyMATIC. Please point out errors for testing purposes. #chemsky #biosky #biotech #adc
210
Pat Sharp @patsharp.bsky.social · 10/03/2025
chatGPT spat this out. Still trying to verify it. Looks reasonable enough by an eyeball test, although THF looks high (higher than thiazole?).
210
Pat Sharp @patsharp.bsky.social · 09/03/2025
Could say the same for Australia
010
Pat Sharp @patsharp.bsky.social · 08/03/2025
I studied gold catalysis in my PhD - looks like there more to bleed from that rock Gold-Catalyzed C(sp3)–C(sp2) Suzuki–Miyaura Coupling Reaction | Organic Letters pubs.acs.org/doi/10.1021/... #chemsky
pubs.acs.org
Gold-Catalyzed C(sp3)–C(sp2) Suzuki–Miyaura Coupling Reaction
A gold-catalyzed C(sp3)–C(sp2) Suzuki–Miyaura coupling reaction facilitated by ligand-enabled Au(I)/Au(III) redox catalysis was developed. The cross-coupling of alkyl organometallics was first realiz...
030
Pat Sharp @patsharp.bsky.social · 07/03/2025
VLE (Volume Ligand Efficiency)? It’s a little known metric in drug design that helps predict low human dose compounds by balancing potency and unbound exposure. It refines drug selection early-ish in lead op. pubs.acs.org/doi/10.1021/...
120
Pat Sharp @patsharp.bsky.social · 05/03/2025
Nah I’m OK thanks
010
Reposted by Pat Sharp
Scott Galloway @profgalloway.com · 03/03/2025
Key takeaway from DOGE: There’s less government fraud/waste than expected.
213115331609
Pat Sharp @patsharp.bsky.social · 04/03/2025
Huge if this translates to humans! Vitamin C - through a protein PTM can boost PD-1 therapy in mice. This has the potential to unlock additional life for cancer patients. www.cell.com/cell/abstrac...
cell.com
Lysine vitcylation is a vitamin C-derived protein modification that enhances STAT1-mediated immune response
Vitamin C directly modifies lysine residues through vitcylation, regulating STAT1 signaling and enhancing anti-tumor immune responses by preventing STAT1 dephosphorylation.
000